-
Disrupting SARS-CoV-2 Nucleocapsid Condensation to Inhibit R
2026-06-05
The referenced study identifies that SARS-CoV-2 nucleocapsid protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), a process vital to viral replication. By demonstrating that (-)-gallocatechin gallate (GCG) can disrupt this condensation and suppress viral replication, the work opens new avenues for targeting phase separation in antiviral research.
-
Bufalin as a Cardiotonic Steroid: TNBC Research Workflows
2026-06-05
Bufalin, a cardiotonic steroid, is redefining cancer research by enabling precision-targeted apoptosis induction and STK33 degradation in triple-negative breast cancer. This article distills the latest evidence into actionable workflows, troubleshooting, and protocol optimization for oncology labs.
-
Plant Cell Lysis Buffer for WB and IP: Precision Protein Ext
2026-06-04
Discover how Plant Cell Lysis Buffer for WB and IP enables high-fidelity protein extraction from plant tissues under non-denaturing conditions. This in-depth analysis explores its scientific advantages for Western blotting and immunoprecipitation, revealing insights overlooked by standard protocols.
-
Ibrexafungerp (MK 3118): Applied Antifungal Assay & Workflow
2026-06-04
Ibrexafungerp (MK 3118) is redefining antifungal research with robust efficacy even against resistant Candida and under acidic conditions that compromise other agents. This guide translates recent breakthroughs into stepwise workflows, troubleshooting tips, and comparative perspectives for researchers tackling real-world mycology challenges.
-
CB-5083: Applied Protocols for Precision p97 Inhibition
2026-06-03
CB-5083 offers researchers a potent, selective avenue to dissect protein homeostasis disruption and cancer cell apoptosis induction. With optimized workflows and troubleshooting strategies, this p97 inhibitor from APExBIO accelerates translational oncology and mechanistic studies.
-
DiscoveryProbe™ Protease Inhibitor Library: Reliable HTS Sol
2026-06-03
This article presents scenario-driven best practices for integrating the DiscoveryProbe™ Protease Inhibitor Library (SKU L1035) into workflows for cell viability, proliferation, and cytotoxicity assays. Drawing from validated protocols, real-world experimental challenges, and supporting literature, it demonstrates how this comprehensive, automation-ready resource elevates assay reliability and data quality in biomedical research.
-
VEGFC–VEGFR-3 Axis Modulation Reduces Liver Fibrosis in NASH
2026-06-02
This study elucidates how targeting the hepatocyte-derived VEGFC–macrophage regulatory axis protects against high-fat diet-induced hepatic fibrosis. The findings reveal that both naringin and the VEGFR-3 inhibitor SAR131675 attenuate liver inflammation and fibrosis by disrupting VEGFC-mediated macrophage recruitment and phenotypic switching, providing a mechanistic framework for anti-lymphangiogenic interventions in NASH.
-
(R,S)-Anatabine: Optimizing Workflows in Alzheimer’s Disease
2026-06-02
(R,S)-Anatabine empowers neurodegeneration researchers to precisely target amyloid-beta production and inflammation in both in vitro and in vivo Alzheimer’s disease models. This guide delivers actionable workflow enhancements, troubleshooting tactics, and protocol parameters that maximize reproducibility and mechanistic insight.
-
EdU Imaging Kits: Precision Cell Proliferation with HF488
2026-06-01
APExBIO’s EdU Imaging Kits (HF488) redefine cell proliferation assays through click chemistry and high-sensitivity DNA synthesis measurement. Discover how this technology enables reproducible, workflow-friendly S-phase detection for advanced oncology research and drug screening.
-
GPR35-KLF5 Circuitry Mediates Epithelial Repair in DSS Colit
2026-06-01
This study uncovers a tryptophan metabolic gatekeeping mechanism in which GPR35 senses mucosal damage and activates KLF5-dependent epithelial repair programming. These mechanistic insights clarify how intestinal epithelial cells decode injury signals, advancing ulcerative colitis research using DSS-induced mouse models.
-
Latrunculin A: Reversible Inhibitor of Actin Assembly in Res
2026-05-31
Latrunculin A from APExBIO stands out as a precise, rapid, and reversible inhibitor of actin assembly, enabling robust experimentation in cytoskeletal and host-pathogen dynamics. This article translates cutting-edge findings into actionable workflows for researchers studying cytoskeleton disaggregation, cell motility, and virus-host interactions.
-
ABT-263 (Navitoclax) in Cancer Biology: Applied Workflows &
2026-05-30
ABT-263 (Navitoclax) is redefining apoptosis research and cancer model optimization through high-affinity inhibition of Bcl-2 family proteins. Learn practical workflows, protocol parameters, and troubleshooting strategies that elevate the precision and reproducibility of apoptosis and senescence assays.
-
Dimethyloxalylglycine (DMOG): Technical Guide for Research U
2026-05-29
Dimethyloxalylglycine (DMOG) enables controlled, reversible stabilization of hypoxia-inducible factors by inhibiting prolyl-4-hydroxylase activity, making it a practical tool for modeling hypoxia signaling and inflammation in vitro and in vivo. Researchers should use DMOG strictly for scientific research applications; its use in diagnostic or clinical settings is not supported.
-
Connexin 43/NF-κB Pathway in AngII-Induced Macrophage Polari
2026-05-29
This study reveals that angiotensin II drives RAW264.7 macrophages toward a pro-inflammatory M1 phenotype via the connexin 43/NF-κB (p65) signaling axis. Targeted inhibition of Cx43 hemichannels, including with Gap19, attenuates both NF-κB activation and M1 polarization, offering mechanistic insight for interventions in inflammation-related cardiovascular disease.
-
Digestive Fate of Withania somnifera Metabolites Revealed by
2026-05-28
This study systematically profiles the digestive transformations of key Withania somnifera (ashwagandha) metabolites using advanced LC-MS/MS and molecular networking. The findings clarify compound-specific stability and transformation during simulated digestion, refining in vitro modeling for botanical pharmacokinetics.